Orbital Floor Fracture Repair by Titanium Mesh Via Transantral Approach.

February 5, 2024 updated by: Aliaa Khalaf Abd Ellatief Mohamed, Cairo University

Feasibility of Patient-specific Titanium Mesh Via A Transantral Approach for Repair of Orbital Floor Fractures.

The aim of the study is to evaluate the feasibility of CAD/CAM osteosynthesis mesh through a transantral surgical approach in the Repair of orbital floor fractures by means of clinical and radiographic findings.

Study Overview

Detailed Description

A CAD/CAM osteosynthesis mesh through a transantral approach should assumingly provide accurate reconstruction of the orbital volume and anatomy while eliminating the usual morbidity of lower eyelid approaches during orbital reconstruction.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of Dentistry,Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

Through the utilization of a trans-antral approach, orbital floor fractures can be easily managed particularly by allowing clear visualization of the posterior edge of the orbital floor. Also, the risk of eyelid deformity and orbital floor periosteum disruption is alleviated.

Transantral visualization as an adjunct to traditional periorbital approaches has shown to improve rates of diplopia and enophthalmos.7 A 2013 review showed the utility of a transantral sublabial approach for surgical repair of an isolated orbital floor defect, including cases that required alloplastic implant or bone graft placement for rigid reconstruction.

Description

Inclusion Criteria:

  • Patients with recent unilateral orbital floor fracture indicated for internal reconstruction -
  • (isolated or in combination with other facial fractures)
  • with existing or estimated enophthalmos based on radiographs and a contra-lateral healthy non-operated orbit.

Exclusion Criteria:

  • Delayed cases (more than 2 weeks)
  • previously operated cases
  • bilateral orbital floor fracture.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: orbital floor fracture
reconstruction of orbital floor fracture by patient specific titanium mesh
Other Names:
  • trans antral orbital floor reconstruction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
enophthamus
Time Frame: 6 months
will calculate the amount of alteration and quantity of Enophthalmos by mean of a Post-Op Soft window CT scan in mm
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Actual)

June 5, 2023

Study Completion (Actual)

July 27, 2023

Study Registration Dates

First Submitted

June 26, 2022

First Submitted That Met QC Criteria

June 26, 2022

First Posted (Actual)

June 30, 2022

Study Record Updates

Last Update Posted (Actual)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orbital Fractures

Clinical Trials on transantral orbital floor reconstruction by titanium mesh

Subscribe